Home
 /
Papers
 /
Microbiology
 /
Mapping unsolved lipidomes accelerates lipid discovery in major bacterial pathogens
Preprint
Open access
V1
Top 1% · Validated by QED

Mapping unsolved lipidomes accelerates lipid discovery in major bacterial pathogens

Yashodhan M. Nair, Aruna R. Menon, Zonghao Lin +14 more
November 2025
 ·
bioRxiv
 ·
DOI 
10.1101/2025.11.06.685907
94
%
Reproducible
QED Impressions
This paper passed independent validation.
QED's automated review checked the evidence supporting each claim, the statistical methods, and whether the results are reproducible from the data provided.

It ranks in the top 1% of preprints assessed in Microbiology this quarter.
Run full QED analysis
Read paper
Save

Why this is interesting

Molecule-forward lipidomic mapping of M. tuberculosis reveals 40 unknown lipid families and exposes lysylDAG as a conserved virulence lipid in Mtb and S. aureus, establishing that these major pathogens' cell envelopes remain chemically unsolved.

QED claims analysis

Summary

Systematic lipidomic mapping of Mycobacterium tuberculosis reveals that over half of detectable lipids remain uncharacterized, enabling the discovery of lysyldiacylglycerol as a conserved virulence lipid produced by the lysX gene in mycobacteria and the mprF gene in Staphylococcus aureus, where lysX disruption attenuates infection across evolutionarily diverse host models.

See full analysis
Main Claim 1 –

Mtb Lipidome Contains 312 Qualified Unknown Lipid Features

Supporting evidence

  • LysylDAG Is Lysine Ester-Linked to sn3 Diacylglycerol
  • LysX Functions as Lysyldiacylglycerol Synthase, Not Phospholipid Modifier
  • lysX Disruption Broadly Alters the Lipidome Beyond LysylDAG
  • Synthetic Standards Confirm Natural LysylDAG Has sn3 Stereochemistry
  • LysylDAG Is Constitutively Produced Across Growth Phases and Media
Main Claim 2 –

LysylDAG Is Universal Across Mycobacteria With Species-Specific Acylforms

Supporting evidence

  • M. marinum lysX Mutation Eliminates LysylDAG, Rescued by Complementation
Main Claim 3 –

lysX Is Required for Mycobacterial Virulence In Vivo

Main Claim 4 –

S. aureus MprF Synthesizes LysylDAG as a Novel Product

Supporting evidence

  • MprF-Domain Proteins Form Three Phylogenetic Clades Across Bacteria
  • S. aureus Produces mprF-Dependent LysylDAG Across Growth Phases

Abstract

Unlike gene-first approaches to understanding bacterial pathogenesis, molecule-forward discovery can uncover unexpected chemical diversity. Here, new lipidomic analytical methods and quality metrics defined the large scope of unknown lipids in the world’s deadliest pathogen, Mycobacterium tuberculosis (Mtb). This map allowed rapid discovery of Mtb lysyldiacylglycerol linked to the biosynthetic gene lysX, which controls in vivo infection outcomes in moth larvae, mice, guinea pigs, and here, zebrafish. A broader search for orthologous lysyltransferase domains identified the Staphylococcus aureus virulence gene mprF, where the same lipoamino acid was shown to be a previously unknown biosynthetic product. Thus, lipidomic mapping showed that the cell envelope composition of well-studied bacterial pathogens remains substantially unsolved and offers a new way to generate lists of discoverable lipids to accelerate molecular discovery.

Related papers

How the QED Score works

QED Score is a validated AI-based quality metric that evaluates life science papers on two dimensions: originality and validity. Each manuscript is anonymized, broken down into its claims and supporting evidence, and examined by specialized AI agents for statistical rigor, consistency across figures, and fit with the existing literature. Scores are percentile ranks, so they're comparable across fields. In blinded tests, expert professors sided with QED Score over journal rank in 75% of decisive cases.
Read the methodology

Free access for academic researchers

Create your free QED account to validate your research, strengthen grant proposals, and uncover scientific insights.
We've sent you an access link.
Please check your inbox.

Didn't get your email? Check your spam folder or reach out to info@qedscience.com

Oops! Something went wrong while submitting the form.
Looking for QED for pharma, biotech or life science organizations?